{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:47:45Z","timestamp":1785426465761,"version":"3.56.0"},"reference-count":28,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2025,10,19]]},"abstract":"<jats:p>In the age of the opioid epidemic and a widespread desire to reduce opioid prescriptions, both in outpatient practices and hospitals, we have welcomed non-opioid medications as one possible strategy to reduce the reliance on opioids for the treatment of pain. For anesthesiologists, surgeons, and other perioperative physicians, minimizing exposure to opioids in the perioperative period has been a focal point for several decades now and countless protocols have been described, adopted, and studied. Gabapentin and pregabalin, known collectively as gabapentinoids, have been included in many of these protocols and it is not difficult to see why. They have predictable pharmacokinetics, are one of the only medication classes to treat neuropathic pain, and have sizeable literature support for their ability to reduce pain and opioid consumption. Their use for acute perioperative pain remains off-label. As with many drugs, we have learned more over time and now have a fuller picture of the benefits and risks associated with gabapentinoids. In particular, the central nervous system adverse effects, including dizziness and sedation, are now well established and can be especially problematic in the elderly. Synergistic respiratory depression when combined with opioids and even possible cognitive deficits from prolonged use have been described, forcing some perioperative physicians to rethink their inclusion in enhanced recovery and other perioperative protocols. In this pro\u2013con discussion, we debate the merits of perioperative gabapentinoids in 2025, relying on published evidence for our positions, and ultimately call for a nuanced approach that considers the individual patient before us.<\/jats:p>","DOI":"10.1136\/rapm-2025-107210","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T02:55:23Z","timestamp":1762397723000},"page":"rapm-2025-107210","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Pro\u2013con debate on perioperative gabapentinoids: a nuanced approach is the best one"],"prefix":"10.1136","author":[{"given":"Kishor","family":"Gandhi","sequence":"first","affiliation":[{"name":"Anesthesiology, Virtua Memorial Hospital Burlington County, Mount Holly, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-4149","authenticated-orcid":false,"given":"Eric S","family":"Schwenk","sequence":"additional","affiliation":[{"name":"Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2025110518551657000_rapm-2025-107210v1.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Med"},{"key":"2025110518551657000_rapm-2025-107210v1.2","doi-asserted-by":"publisher","DOI":"10.1177\/1178221818801311"},{"key":"2025110518551657000_rapm-2025-107210v1.3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025110518551657000_rapm-2025-107210v1.4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamainternmed.2022.3680","article-title":"Perioperative Gabapentin Use and In-Hospital Adverse Clinical Events Among Older Adults After Major Surgery","volume":"182","author":"Park","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2025110518551657000_rapm-2025-107210v1.5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamasurg.2017.4915","article-title":"Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial","volume":"153","author":"Hah","year":"2018","journal-title":"JAMA Surg"},{"key":"2025110518551657000_rapm-2025-107210v1.6","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200209000-00007"},{"key":"2025110518551657000_rapm-2025-107210v1.7","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000257"},{"key":"2025110518551657000_rapm-2025-107210v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91123-R"},{"key":"2025110518551657000_rapm-2025-107210v1.9","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0057-y"},{"key":"2025110518551657000_rapm-2025-107210v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0"},{"key":"2025110518551657000_rapm-2025-107210v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rapm.2006.01.005"},{"key":"2025110518551657000_rapm-2025-107210v1.12","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000309"},{"key":"2025110518551657000_rapm-2025-107210v1.13","article-title":"The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery","volume":"97","author":"Jiang","year":"2018","journal-title":"Medicine (Abingdon)"},{"key":"2025110518551657000_rapm-2025-107210v1.14","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000"},{"key":"2025110518551657000_rapm-2025-107210v1.15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamasurg.2017.0898","article-title":"Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review","volume":"152","author":"Wick","year":"2017","journal-title":"JAMA Surg"},{"key":"2025110518551657000_rapm-2025-107210v1.16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5055\/jom.2021.0635","article-title":"Perioperative gabapentinoid use lowers short-term opioid consumption following lower limb arthroplasty: Systematic review and meta-analysis","volume":"17","author":"Campbell","year":"2021","journal-title":"J Opioid Manag"},{"key":"2025110518551657000_rapm-2025-107210v1.17","article-title":"A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Abingdon)"},{"key":"2025110518551657000_rapm-2025-107210v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25636"},{"key":"2025110518551657000_rapm-2025-107210v1.19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11916-022-01009-x","article-title":"Enhanced Recovery After Surgery: Opioid Sparing Strategies After Discharge: A Review","volume":"26","author":"Rajput","year":"2022","journal-title":"Curr Pain Headache Rep"},{"key":"2025110518551657000_rapm-2025-107210v1.20","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003428"},{"key":"2025110518551657000_rapm-2025-107210v1.21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1213\/ANE.0000000000005656","article-title":"Day-of-Surgery Gabapentinoids and Prolonged Opioid Use: A Retrospective Cohort Study of Medicare Patients Using Electronic Health Records","volume":"133","author":"Young","year":"2021","journal-title":"Anesth Analg"},{"key":"2025110518551657000_rapm-2025-107210v1.22","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.arth.2022.05.018","article-title":"Perioperative Use of Gabapentinoids and Risk for Postoperative Long-Term Opioid Use in Older Adults Undergoing Total Knee or Hip Arthroplasty","volume":"37","author":"Chen","year":"2022","journal-title":"J Arthroplasty"},{"key":"2025110518551657000_rapm-2025-107210v1.23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bja.2017.11.113","article-title":"Pattern of perioperative gabapentinoid use and risk for postoperative naloxone administration","volume":"120","author":"Deljou","year":"2018","journal-title":"Br J Anaesth"},{"key":"2025110518551657000_rapm-2025-107210v1.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18626","article-title":"Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults","volume":"6","author":"Bongiovanni","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025110518551657000_rapm-2025-107210v1.25","unstructured":"Fda warns about serious breathing problems with seizure and nerve pain medicines gabapentin (neurontin, gralise, horizant) and pregabalin (lyrica, lyrica cr). Available: https:\/\/www.fda.gov\/media\/133681\/download [Accessed 6 Sep 2025]."},{"key":"2025110518551657000_rapm-2025-107210v1.26","doi-asserted-by":"crossref","unstructured":"Eghrari NB , Yazji IH , Yavari B , et al . Risk of dementia following gabapentin prescription in chronic low back pain patients. Reg Anesth Pain Med 2025. doi:10.1136\/rapm-2025-106577","DOI":"10.1136\/rapm-2025-106577"},{"key":"2025110518551657000_rapm-2025-107210v1.27","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000173"},{"key":"2025110518551657000_rapm-2025-107210v1.28","doi-asserted-by":"crossref","DOI":"10.1111\/add.13324","article-title":"Abuse and Diversion: A Systematic Review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2025-107210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T02:55:26Z","timestamp":1762397726000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2025-107210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":28,"alternative-id":["10.1136\/rapm-2025-107210"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2025-107210","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}